Skip to main content
. 2021 Dec 21;6(4):841–854. doi: 10.1002/hep4.1857

FIG. 3.

FIG. 3

HBV‐specific TCR T‐cell therapy induced observable immunological alterations in the peripheral blood. (A) Longitudinal frequencies of peripheral blood activated and proliferating (Ki67+ CD39+) CD8 and CD4 T cells. (B) Serum concentrations of CXCL9 and CXCL10 of all patients treated with HBV‐specific TCR T cells. Serum ALT levels and the number of HBV‐specific TCR T cells infused are indicated as before. *Patients with reported adverse events.